?Product Overview?
Allopregnanolone (CAS: 516-54-1), a neuroactive steroid, is a potent endogenous modulator of GABA_A receptors. It regulates neuronal excitability and stress responses, making it critical for treating neurological disorders like postpartum depression and epilepsy. This white crystalline powder also serves as a key ingredient in anti-aging cosmetics and pharmaceutical research intermediates.

? ?Key Advantages?
? ?High Purity?: ≥99% purity (HPLC/GC tested) for pharmaceutical and research applications.
? ?Neuroprotective Activity?: Demonstrates EC₅₀ values of 10-50 nM in GABA_A receptor modulation.
? ?Thermal Stability?: Melting point 176-178°C ensures stability during formulation and storage.

?? ?Application Fields?

• ?Pharmaceuticals?: Core component in treatments for postpartum depression, epilepsy, and neurodegenerative diseases.

• ?Cosmetics?: Enhances anti-aging formulations by promoting cellular repair and skin resilience.

• ?Research?: Vital for neurosteroid studies and drug development targeting GABA pathways.

?? ?Quality Assurance?

• Produced in ?GMP-certified facilities? with compliance to EP/USP standards.

• Rigorous quality control via ?HPLC, NMR, and mass spectrometry? for batch consistency.

• Complies with ?MSDS safety guidelines? for safe handling and storage.

?? ?Market Insights?
The global neurosteroid market is projected to grow at a ?CAGR of 7.8% (2025-2030)?, driven by rising demand for non-hormonal antidepressants and neurological therapies. Allopregnanolone’s role in the ?$1.2B postpartum depression treatment market? underscores its commercial significance.